E. Lopez-Quesada

发表

Shared risk factors for COVID‐19 and preeclampsia in the first trimester: An observational study

E. Carreras, N. Maiz, E. Sulleiro, 2022, Acta obstetricia et gynecologica Scandinavica.

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

E. Carreras, M. Gil, A. Maroto, 2022, JMIR research protocols.

Contingent screening for Down syndrome completed in the first trimester: a multicenter study

G. Falguera, A. Acera, D. Guix, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[Homocysteine and pregnancy].

M. Vilaseca, E. Lopez-Quesada, S. González, 2000, Medicina clinica.

Next-Generation Sequencing Gene Panels and “Solo” Clinical Exome Sequencing Applied in Structurally Abnormal Fetuses

M. Pauta, E. Eixarch, A. Nadal, 2021, Fetal Diagnosis and Therapy.

Are plasma total homocysteine and other amino acids associated with glucose intolerance in uncomplicated pregnancies and preeclampsia?

J. Lailla, M. Antònia Vilaseca, E. Lopez-Quesada, 2005, European journal of obstetrics, gynecology, and reproductive biology.

Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia.

M. Vilaseca, J. Lailla, E. Lopez-Quesada, 2003, European journal of obstetrics, gynecology, and reproductive biology.

Homocysteine and other plasma amino acids in preeclampsia and in pregnancies without complications.

R. Artuch, M. Vilaseca, J. Lailla, 2003, Clinical biochemistry.

Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies.

D. Grinberg, S. Balcells, M. Vilaseca, 2005, European Journal of Obstetrics, Gynecology, and Reproductive Biology.

Perinatal outcome prediction by maternal homocysteine and uterine artery Doppler velocimetry.

M. Vilaseca, J. Lailla, A. Vela, 2004, European journal of obstetrics, gynecology, and reproductive biology.

Implementation of routine first‐trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness study

E. Carreras, A. Maroto, M. Mendoza, 2022, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Impact of thyroid universal screening on pregnancy outcomes in real‐world clinical practice

M. Barahona, V. Perea, A. Orois, 2022, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor

A. Maroto, M. Mendoza, E. Bonacina, 2023, Acta obstetricia et gynecologica Scandinavica.

Mid‐trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre‐eclampsia: Post‐hoc analysis of StopPRE trial

E. Carreras, A. Maroto, M. Mendoza, 2023, BJOG : an international journal of obstetrics and gynaecology.

Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.

E. Carreras, A. Maroto, M. Mendoza, 2023, JAMA.